<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T20:52:34Z</responseDate>
  <request identifier="oai:figshare.com:article/31894381" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/31894381</identifier>
        <datestamp>2026-09-30T21:16:17Z</datestamp>
        <setSpec>category_27052</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Supplementary material 2 - Zambia TAS-1 LF Wb Ag prevalence and EU classification outcomes</dc:title>
          <dc:creator>Belem B. Matapo (23650909)</dc:creator>
          <dc:subject>Epidemiological methods</dc:subject>
          <dc:subject>EU name</dc:subject>
          <dc:subject>LF prevalence per EU</dc:subject>
          <dc:subject>EU pass or EU fail</dc:subject>
          <dc:description>&lt;p dir="ltr"&gt;&lt;b&gt;Zambia TAS‑1 LF Wb Ag Prevalence and EU Classification Outcomes&lt;/b&gt;&lt;/p&gt;&lt;p dir="ltr"&gt;This dataset contains the &lt;i&gt;Wuchereria bancrofti&lt;/i&gt; antigen (Wb Ag) prevalence results and corresponding Evaluation Unit (EU) classification outcomes from Zambia’s first Transmission Assessment Survey (TAS‑1) for lymphatic filariasis (LF). The dataset provides EU‑level and school‑level antigen testing results used to determine whether each EU met the WHO criteria to stop mass drug administration (MDA) and transition to post‑MDA surveillance.&lt;/p&gt;&lt;p dir="ltr"&gt;The dataset includes the number of children tested, the number of antigen‑positive results, calculated Wb Ag prevalence, and the final TAS‑1 pass/fail classification for each EU. These outcomes were derived using WHO TAS decision rules and critical cut‑off thresholds. The data support transparency in LF program decision‑making and enable secondary analyses, methodological reviews, and TAS-1 will be a future baseline comparison with TAS‑2 and TAS‑3 outcomes.&lt;/p&gt;&lt;p dir="ltr"&gt;&lt;b&gt;Contents include:&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Evaluation Unit (EU) identifiers&lt;/li&gt;&lt;li&gt;Districts included in each EU&lt;/li&gt;&lt;li&gt;Number of schools surveyed&lt;/li&gt;&lt;li&gt;Number of children tested&lt;/li&gt;&lt;li&gt;Number of Wb Ag‑positive children&lt;/li&gt;&lt;li&gt;EU‑level Wb Ag prevalence&lt;/li&gt;&lt;li&gt;WHO TAS‑1 critical cut‑off values&lt;/li&gt;&lt;li&gt;EU classification outcome (Pass/Fail)&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;/p&gt;</dc:description>
          <dc:date>2026-03-31T05:50:21Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.6084/m9.figshare.31894381.v2</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Supplementary_material_2_-_Zambia_TAS-1_LF_Wb_Ag_prevalence_and_EU_classification_outcomes/31894381</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
